NFL Biosciences Secures Initial Non-Dilutive Funding of €1.2 Million, Adding to Its Recent Capital Increase, to Advance the Development of NFL-101, Its First-in-Class Treatment for Tobacco Addiction
NFL BIOSCIENCES (Euronext Growth Paris - FR0014003XT0 - ALNFL), a biopharmaceutical company developing innovative botanical medicines for the treatment of addiction, today announced that it has secured €1.2 million in medium-term non-dilutive financing from three partners.
NFL Biosciences obtained a €600,000 'Innovation Advance' repayable advance from Bpifrance. This advance will be repaid interest-free over 5 years starting in the second quarter of 2029, in quarterly instalments of €30,000. The company has also secured two medium-term loans totalling €600,000 from its banking partners, repayable over 4 and 5 years at a fixed rate.
This €1.2 million adds to the €3.0 million raised in the oversubscribed capital increase at the end of May 2025. The company also expects to secure additional non-dilutive funding and plans to benefit each year from the reimbursement of a portion of its R&D expenses through the Research Tax Credit. These funds are allocated to the continued development of NFL-101, its proprietary drug indicated for smoking cessation.
The company is currently engaged in scientific advice procedures with European regulatory authorities and the FDA. The feedback expected at the end of the summer will enable the company to confirm its development strategy, notably in relation to manufacturing, preclinical and clinical aspects.
'We would like to sincerely thank Bpifrance for its support, as well as our banking partners Société Générale and Banque Populaire du Sud. We have recently secured €4.2 million to support our development, and we are confidently approaching the launch of Phase 3. We are also continuing to seek additional non-dilutive funding and remain focused on rigorously managing our structural costs,' commented Bruno Lafont, Chief Executive Officer of NFL Biosciences.
About NFL Biosciences: www.nflbiosciences.com
NFL Biosciences is a biopharmaceutical company based in the Montpellier region of France, developing plant-based drug candidates for the treatment of addictions. NFL Biosciences' ambition is to bring new, safer and more effective natural therapeutic solutions to the entire world population, including low- and middle-income countries. Its most advanced product, NFL-101, is a standardized tobacco leaf extract protected by three patent families. NFL Biosciences intends to offer smokers wishing to quit a natural, safe, easy-to-administer and personalized alternative. NFL Biosciences is also developing NFL-301, a natural drug candidate for the reduction of alcohol consumption and has a drug development project for the treatment of cannabis use disorders.
NFL Biosciences shares are listed on Euronext Growth Paris (FR0014003XT0 - ALNFL). The company is qualified as an 'Innovative Company' eligible for FCPI investment. More information on www.nflbiosciences.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
18 minutes ago
- Yahoo
Institutional Investors Say Markets Are Underestimating Tariff Impact; Many Pull Back on U.S. Stocks, Finds CoreData Research
Nearly eight in 10 institutional investors are making tactical or longer-term strategic shifts in the face of volatile U.S. trade policy. Seven in 10 worry that tariff policies will accelerate a global shift away from treasuries and the U.S. dollar. A third think the U.S. and China will fail to make a deal and reinstate trade barriers that will unleash major economic disruption. Nearly half think the markets are too complacent about tariff impacts. U.S. stocks are widely expected to underperform compared to other markets. BOSTON, July 29, 2025--(BUSINESS WIRE)--Institutional investors are revamping portfolios through tactical tweaks and strategic shifts as they brace for heightened turbulence triggered by volatile U.S. trade policy, according to new survey data from CoreData Research. CoreData conducted a pulse survey of 132 institutional investors and 22 institutional consultants who collectively manage or oversee more than $4.9 trillion in assets. Nearly half (49%) of respondents believe the markets are too complacent about the impact of U.S. trade policies. While the S&P 500 has stormed back from its initial freefall in April, 56% of institutions hold a bearish view on U.S. equity markets over the next three months – the most pessimistic outlook of all regional equity markets. As early tariff moves begin to bite, CoreData found that institutional investors aren't waiting around for more clarity to act. Nearly half (49%) have already made tactical portfolio changes in response to shifting U.S. trade policies, and 47% have or plan to make changes in their strategic allocations. European and Asian institutions have been more inclined to take action, with more than half already making significant portfolio changes compared to just 36% of U.S. institutions so far. In the case of Europe, this may be because European institutions are more bearish (65%) in their near-term outlook for U.S. equity markets than peers in the U.S. (49%). When asked about their base case for the outcome of President Trump's trade policy negotiations with China, the survey found: 66% of respondents are optimistic that a U.S. China trade agreement will be reached within the next year, limiting market disruption. U.S. investors (69%) are more optimistic than peers in Europe (58%). 32% overall believe the U.S. and China will not be able to reach a trade agreement and will reinstate trade barriers that lead to significant economic disruption. "The research suggests that any optimism institutional investors have about the world's most important trade negotiations belies a sense that global trade already has irrevocably changed, and thus, portfolio construction must adapt to a new reality," said Michael Morley, head of CoreData U.S. "With a wide range of economic scenarios now very much in play, institutions are looking at ways to de-risk and build greater portfolio resilience." Tactical Shifts Point to Proactive Risk Mitigation Among investors making tactical adjustments 56% have reduced exposure to U.S. assets, including 48% of U.S. institutions and 63% in Europe. 49% have trimmed exposure to trade-sensitive assets. 44% are hedging exposure to the U.S. dollar, including 32% of U.S. institutions and 47% in Europe. Other tactical changes include rotating to value stocks and/or defensive sectors (41%) or increasing cash allocations (40%). Few (20%) reported increasing commodities exposure. Long-Term Strategic Repositioning Underway The long-term picture also points to a reduction in U.S. exposures as other developed markets suddenly look much more attractive. Notably, the survey found: 69% of institutions believe evolving tariff policies will accelerate a global shift away from treasuries and the U.S. dollar, including 59% in the U.S. and 82% in Europe. Indeed, 51% of those making strategic allocation shifts are pivoting away from these safe haven assets (highest among European institutions, 69% compared to 33% in the U.S.). 64% expect President Trump's trade policies will lead to structurally higher inflation and slower economic growth. 62% believe that sustained downward pressure on the dollar would lead to transformative change to the financial system, forcing institutions into more significant portfolio changes. About one-third (33%) are shifting to a more conservative asset allocation, increasing exposure to hedge funds/low volatility strategies (35%), or increasing exposure to inflation-hedging assets (32%) such as real assets. "Institutions are demonstrating a much nimbler reaction function than we have seen in the past with respect to strategic allocation changes," added Morley. "Ex-U.S. developed markets and dollar and treasury alternatives are set to be the main beneficiaries. Trump's initial tariffs have done little damage to date, but investors are clearly worried about the long-term impacts." More insights from CoreData can be found at Methodology The 2025 CoreData Institutional Investor Pulse Survey is based on responses from 154 global institutional investors collected in Q2 2025. Respondents include public and private pensions, insurers, foundations, endowments, family offices, and institutional investment consultants. About CoreData Research CoreData Research is a global research firm providing research-driven insights on the priorities and challenges facing financial institutions, advisors and influencers. CoreData's deep understanding of the broad financial services market is driven by world-class research capabilities and a global network of partners with a focus on fund management, wealth management, asset allocators, thought leadership and brand. Founded in 2002, CoreData has offices throughout Europe, the Americas and Asia-Pacific, with its U.S. headquarters in Boston. For more about CoreData, visit View source version on Contacts Media contactJared 617-702-3392 Sign in to access your portfolio
Yahoo
18 minutes ago
- Yahoo
Stellantis to absorb $1.7 billion in tariff costs in 2025
Big Three automaker Stellantis (STLA) updated its first half financials after releasing preliminary figures last week, noting that President Trump's tariffs will cost 1.5 billion euros ($1.73 billion) in 2025. Stellantis did however reinstate financial guidance for the year. Stellantis — which counts brands like Ram, Jeep, Fiat, and Alfa Romeo in its product portfolio — said it revenues in the first half of 2025 to come in at 74.3 billion euros ($86.13 billion), down 13% year over resulting in a net loss of 2.3 billion euros ($2.67 billion). Last year in the same period Stellantis reported 5.6 billion euros ($6.48 billion) in net profit. Stellantis said adjusted operating income (AOI) came in at 500 million euros ($579.6 million), with cash flows from operating activities slipping to a loss of 2.3 billion euros ($2.67 billion). With that said, Stellantis now projects new guidance for the second half of the year and expects to see increased net revenues, low-single digit AOI profitability, and improved industrial free cash flow results. Stellantis said this assumes current tariff and trade rules in place as of July 29, 2025. Stellantis stock was down 4% in the pre-market. "2025 is turning out to be a tough year, but also one of gradual improvement. Signs of progress are evident when comparing H1 2025 to H2 2024, in the form of improved volumes, net revenues, and AOI, despite intensifying external headwinds," new CEO Antonio Filosa said in a statement. Stellantis said last week that it absorbed approximately 300 million euros ($347.77 million) in tariff-related costs as well as loss of planned production in the first half of the year. Two months ago, Stellantis selected Filosa, a 25-year veteran of the company and Americas COO, as its new chief executive. His tenure began on June 23, with interim CEO John Elkann remaining as executive chair. Filosa has his hands full repairing the Stellantis business. For the second quarter, Stellantis said global deliveries fell to 1.447 million units from 1.537 million a year ago, down 6%. Sales tumbled in the US 25%, while the greater European region saw sales drop 6%. Stellantis has been trying to pare bloated inventories in the US with pricing incentives and production cuts, and those measures have helped. But the big question remains, at least in the US, of the effect of auto sector tariffs targeting Canada and Mexico production. Stellantis makes several vehicles in Canada and Mexico, where 25% sector tariffs apply to all imports, in addition to auto parts tariffs. Last quarter, Stellantis idled production at plants in Canada and Mexico as a result of tariffs. Read more: 5 ways to tariff-proof your finances A just-announced US-EU tariff deal could help Stellantis, but issues including unpopular vehicles and existing tariffs for Canadian and Mexican imports will still be a problem. Pras Subramanian is the lead auto reporter for Yahoo Finance. You can follow him on X and on Instagram.
USA Today
19 minutes ago
- USA Today
Trump's trade talks intensify with tariff deadline fast approaching
TACO or tariffs? An August 1 deadline looms after the European Union became the latest of the top US trading partners to reach a deal with Trump. WASHINGTON — With President Donald Trump's Aug. 1 tariff deadline fast approaching, countries whose exports are facing stiff fees have been in a scramble to ink trade deals with the United States that preserve as much access as possible to American markets. The European Union and its 27 member nation bloc became the latest of the United States' top trading partners to come to an agreement with Trump over the weekend, joining the Philippines, Japan and Indonesia in announcing deals during July. The United Kingdom and Vietnam have also reached agreements with Trump. Canadian Prime Minister Mark Carney said this week that his country was in the "intense phase" of the complex negotiations, as it sought to avert a promised 35% tariff on imports that fall outside of an existing trade pact with the United States. More: Trump's trade deal with the EU: What it means for your wallet "There is a landing zone that's possible but we have to get there. We'll see what happens," Carney told reporters during a July 28 news conference. 'No more extensions,' Trump administration warns A baseline tariff of 10% is currently in place for most countries, some two dozen of which received letters from Trump this month informing them that higher rates are on the way. They include Brazil, which Trump says he'll hit with a 50% tariff, and India, which he said he'll apply a 26% rate to, as well as Canada, at 35%, and Mexico, which faces a 30% tariff. Mexico, Canada and EU are the the largest exporters of goods to the United States along with China, which is in separate trade talks with the Trump administration and faces a later deadline in August. First announced on April 2 by Trump in the Rose Garden, the implementation of the so-called 'reciprocal tariffs' were twice extended to stabilize the markets and give the president's team more time to conduct negotiations. The constant deadline shifting has given birth to an acronym: TACO, for Trump Always Chickens Out, mocking the second-term president's on-again-off-again tariff policies. More: Trump threatens 35% tariff for Canada amid flurry of letters threatening hikes But countries hoping for another reprieve won't be so fortunate, Commerce Secretary Howard Lutnick said on July 27. 'No extensions, no more grace periods. Aug. 1, the tariffs are set, they'll go into place. Customs will start collecting the money, and off we go,' Lutnick said on 'Fox News Sunday.' EU latest to strike trade deal with Trump Just ahead of the deadline, on July 27, the European Union struck a deal with Trump. European Commission President Ursula von der Leyen and Trump finalized the agreement in person while the U.S. president was in Scotland. The deal includes a 15% tariff on most European exports to the United States, a reduction from the 30% Trump threatened to impose earlier in July. 'We just had a very big trade deal, the biggest of them all yesterday,' Trump said during a bilateral meeting in Scotland on July 28 with U.K. Prime Minister Kier Starmer at Trump Turnberry golf course. The agreement includes $600 billion in EU investments in the U.S. and the purchase of $750 billion worth of U.S. energy. Tariffs on steel and aluminum will remain at 50%. On July 22, Trump also announced a 'massive deal' with Japan under which the United States would impose a 15% tariff on Japanese imports. Trump had previously threatened a 24% tariff on Japan. He said Japan would invest $550 billion in the United States and America would receive 90% of the profits, without offering any details. Trump's announcement also said Japan had agreed to open its markets to imports of vehicles, rice and other agricultural products from the United States. The U.K. was the first country to reach a trade agreement with the United States in May. A reciprocal tariff of 10% remains in effect, in keeping with the baseline tariff rate. More: Trump considers 'rebates' to US taxpayers from tariff income Under the deal, the first 100,000 vehicles imported into the U.S. by U.K. car manufacturers each year are subject to the reciprocal rate of 10% and any additional vehicles each year are subject to 25% rates, the White House says. The U.K is one of the only countries with whom the U.S. has a trade surplus. Trump has also announced deals with Indonesia, Vietnam and the Philippines. 'We've made the big ones,' says Trump Pakistan's foreign minister said on July 25 after a meeting with Secretary of State Marco Rubio that his country was "very close" to reaching a deal with the United States and one could emerge in days. South Korean officials were also in Washington on July 25, for negotiations with Lutnick and other Trump administration officials. Trump signaled during his meeting with Starmer on July 28 that he'd landed most of the deals he expected to and his patience was waning for individual talks. "We're going to be setting a tariff for essentially the rest of the world and that's what they're going to pay if they want to do business in the United States. Because you can't sit down and make 200 deals," Trump declared. "But we've made the big ones." One of the last outstanding agreements of significance is an unfinished deal with China. After rounds of tit-for-tat tariffs that saw the U.S. hike fees on imports to 145% and China put tariffs of 125% on U.S. goods, the nations two called a truce in May, agreeing to a 90-day suspension of the levies. Negotiators from both countries met in Stockholm on July 28 for another round of discussions, with the clock ticking toward the Aug. 12 expiration of the temporary truce between the top economies. "We have a good relationship with China, but China is tough," Trump during his meeting with Starmer in Scotland.
